Image

Test-Retest Reliability of a Submaximal Exercise Test in Patients With Hip and Knee Osteoarthritis

Test-Retest Reliability of a Submaximal Exercise Test in Patients With Hip and Knee Osteoarthritis

Recruiting
30 years and older
All
Phase N/A

Powered by AI

Overview

The aim is to evaluate the test-retest reliability of the primary care-adapted Ekblom-Bak submaximal ergometer bicycle test in patients with hip- and/or knee osteoarthritis (OA).

Forty patients with hip- and/or knee OA eligible for the Swedish national OA treatment program in primary care are to be recruited. After screening for contraindications, participants will perform the aEB-test twice within 1-2 weeks.

The investigators hypothezise that the test will demonstrate acceptable test-retest reliability in patients with hip- and/or knee OA.

To establish reliability is essential for future studies using this test in this population and may support its integration into routine clinical assessment.

Eligibility

Inclusion Criteria:

  • Currently listed on the waiting list for an osteoarthritis rehabilitation program due to clinically diagnosed hip and/or knee osteoarthritis.

Exclusion Criteria:

  • Another primary cause of symptoms or disability, such as inflammatory joint disease or fracture.
  • Another condition currently causing more symptoms than osteoarthritis, for example fibromyalgia.
  • Insufficient understanding of written and spoken Swedish.
  • Medication that affects heart rate.
  • Contraindications for a submaximal ergometer bicycle test according to the screening protocol, such as heart disease.

Study details
    Osteo Arthritis Knee and Hip

NCT07383740

Vastra Gotaland Region

22 August 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.